The Predictive Value of Atherogenic Index of Plasma, Non- High Density Lipoprotein Cholesterol (Non-HDL-C), Non-HDL-C/HDL-C, and Lipoprotein Combine Index for Stroke Incidence and Prognosis in Maintenance Hemodialysis Patients

References

• Rosselli D, Rueda JD, Diaz CE. Cost-effectiveness of kidney transplantation compared with chronic dialysis in end-stage renal disease. Saudi J Kidney Dis Transpl. 2015;26(4):733–738. doi:10.4103/1319-2442.160175
   PubMed Web of Science ®Google Scholar
• Himmelfarb J, Vanholder R, Mehrotra R, Tonelli M. The current and future landscape of dialysis. Nat Rev Nephrol. 2020;16(10):573–585. doi:10.1038/s41581-020-0315-4
   PubMed Web of Science ®Google Scholar
• Herpich F, Rincon F. Management of acute ischemic stroke. Crit Care Med. 2020;48(11):1654–1663. doi:10.1097/CCM.0000000000004597
   PubMed Web of Science ®Google Scholar
• Kelly DM, Ademi Z, Doehner W, et al. Chronic kidney disease and cerebrovascular disease: consensus and guidance from a KDIGO controversies conference. Stroke. 2021;52(7):e328–e346. doi:10.1161/STROKEAHA.120.029680
   PubMed Web of Science ®Google Scholar
• Findlay M, MacIsaac R, MacLeod MJ, et al. Renal replacement modality and stroke risk in end-stage renal disease-a national registry study. Nephrol Dial Transplant. 2018;33(9):1564–1571. doi:10.1093/ndt/gfx291
   PubMed Web of Science ®Google Scholar
• Wetmore JB, Phadnis MA, Ellerbeck EF, Shireman TI, Rigler SK, Mahnken JD. Relationship between stroke and mortality in dialysis patients. Clin J Am Soc Nephrol. 2015;10(1):80–89. doi:10.2215/CJN.02900314
   PubMed Web of Science ®Google Scholar
• Findlay MD, Thomson PC, Fulton RL, et al. Risk factors of ischemic stroke and subsequent outcome in patients receiving hemodialysis. Stroke. 2015;46(9):2477–2481. doi:10.1161/STROKEAHA.115.009095
   PubMed Web of Science ®Google Scholar
• Sato K, Konta Y, Furuta K, et al. Prognostic factors for acute ischemic stroke in patients undergoing hemodialysis. Clin Exp Nephrol. 2022;26(3):286–293. doi:10.1007/s10157-021-02146-0
   PubMed Web of Science ®Google Scholar
• Hofstra L, Tordoir JH, Kitslaar PJ, Hoeks AP, Daemen MJ. Enhanced cellular proliferation in intact stenotic lesions derived from human arteriovenous fistulas and peripheral bypass grafts. Does it correlate with flow parameters? Circulation. 1996;94(6):1283–1290. doi:10.1161/01.cir.94.6.1283
   PubMed Web of Science ®Google Scholar
• Banerjee C, Chimowitz MI. Stroke caused by atherosclerosis of the major intracranial arteries. Circ Res. 2017;120(3):502–513. doi:10.1161/CIRCRESAHA.116.308441
   PubMed Web of Science ®Google Scholar
• Yang M, Kholmukhamedov A. Platelet reactivity in dyslipidemia: atherothrombotic signaling and therapeutic implications. Rev Cardiovasc Med. 2021;22(1):67–81. doi:10.31083/j.rcm.2021.01.256
   PubMed Web of Science ®Google Scholar
• Jiang H, Ruan Z, Wang Z, et al. Simvastatin reduces atherosclerotic plaques and endothelial inflammatory response in atherosclerosis rats through TGF-beta/Smad pathway. Minerva Med. 2020;111(5):504–507. doi:10.23736/S0026-4806.19.06119-6
   PubMed Web of Science ®Google Scholar
• Cai X, Li X, Li L, et al. Adiponectin reduces carotid atherosclerotic plaque formation in ApoE-/- mice: roles of oxidative and nitrosative stress and inducible nitric oxide synthase. Mol Med Rep. 2015;11(3):1715–1721. doi:10.3892/mmr.2014.2947
   PubMed Web of Science ®Google Scholar
• Kalantar-Zadeh K, Block G, Horwich T, Fonarow GC. Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure. J Am Coll Cardiol. 2004;43(8):1439–1444. doi:10.1016/j.jacc.2003.11.039
   PubMed Web of Science ®Google Scholar
• Zhan Y, Xu T, Tan X. Two parameters reflect lipid-driven inflammatory state in acute coronary syndrome: atherogenic index of plasma, neutrophil-lymphocyte ratio. BMC Cardiovasc Disord. 2016;16:96. doi:10.1186/s12872-016-0274-7
   PubMed Web of Science ®Google Scholar
• Yildiz G, Duman A, Aydin H, et al. Evaluation of association between atherogenic index of plasma and intima-media thickness of the carotid artery for subclinic atherosclerosis in patients on maintenance hemodialysis. Hemodial Int. 2013;17(3):397–405. doi:10.1111/hdi.12041
   PubMed Web of Science ®Google Scholar
• Wanner C, Krane V. Non-high-density lipoprotein cholesterol: a target of lipid-lowering in dialysis patients. Am J Kidney Dis. 2003;41(3 Suppl 1):S72–S75. doi:10.1053/ajkd.2003.50089
   PubMed Web of Science ®Google Scholar
• Oguntola SO, Hassan MO, Duarte R, et al. Atherosclerotic vascular disease and its correlates in stable black South African kidney transplant recipients. Int J Nephrol Renovasc Dis. 2018;11:187–193. doi:10.2147/IJNRD.S160553
   PubMed Web of Science ®Google Scholar
• Qin G, Tu J, Zhang C, et al. The value of the apoB/apoAIota ratio and the non-HDL-C/HDL-C ratio in predicting carotid atherosclerosis among Chinese individuals with metabolic syndrome: a cross-sectional study. Lipids Health Dis. 2015;14:24. doi:10.1186/s12944-015-0023-4
   PubMed Web of Science ®Google Scholar
• Chang TI, Streja E, Ko GJ, et al. Inverse association between serum non-high-density lipoprotein cholesterol levels and mortality in patients undergoing incident hemodialysis. J Am Heart Assoc. 2018;7(12). doi:10.1161/JAHA.118.009096
   Web of Science ®Google Scholar
• Moradi H, Vaziri ND. Molecular mechanisms of disorders of lipid metabolism in chronic kidney disease. Front Biosci. 2018;23(1):146–161. doi:10.2741/4585
   Google Scholar
• Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344–e418. doi:10.1161/STR.0000000000000211
   PubMed Web of Science ®Google Scholar
• Huybrechts KF, Caro JJ, Xenakis JJ, Vemmos KN. The prognostic value of the modified Rankin Scale score for long-term survival after first-ever stroke. Results from the Athens Stroke Registry. Cerebrovasc Dis. 2008;26(4):381–387. doi:10.1159/000151678
   PubMed Web of Science ®Google Scholar
• McArthur K, Fan Y, Pei Z, Quinn T. Optimising outcome assessment to improve quality and efficiency of stroke trials. Expert Rev Pharmacoecon Outcomes Res. 2014;14(1):101–111. doi:10.1586/14737167.2014.870479
   PubMed Web of Science ®Google Scholar
• Tariq N, Adil MM, Saeed F, Chaudhry SA, Qureshi AI. Outcomes of thrombolytic treatment for acute ischemic stroke in dialysis-dependent patients in the United States. J Stroke Cerebrovasc Dis. 2013;22(8):e354–e359. doi:10.1016/j.jstrokecerebrovasdis.2013.03.016
   PubMed Web of Science ®Google Scholar
• Wanner C, Tonelli M; Kidney Disease: Improving Global Outcomes Lipid Guideline Development Work Group M. KDIGO Clinical Practice Guideline for Lipid Management in CKD: summary of recommendation statements and clinical approach to the patient. Kidney Int. 2014;85(6):1303–1309. doi:10.1038/ki.2014.31
   PubMed Web of Science ®Google Scholar
• Lee MJ, Park JT, Han SH, et al. The atherogenic index of plasma and the risk of mortality in incident dialysis patients: results from a nationwide prospective cohort in Korea. PLoS One. 2017;12(5):e0177499. doi:10.1371/journal.pone.0177499
   PubMed Web of Science ®Google Scholar
• Dobiasova M, Frohlich J. The plasma parameter log (TG/HDL-C) as an atherogenic index: correlation with lipoprotein particle size and esterification rate in apoB-lipoprotein-depleted plasma (FER(HDL)). Clin Biochem. 2001;34(7):583–588. doi:10.1016/s0009-9120(01)00263-6
   PubMed Web of Science ®Google Scholar
• Cai G, Shi G, Xue S, Lu W. The atherogenic index of plasma is a strong and independent predictor for coronary artery disease in the Chinese Han population. Medicine. 2017;96(37):e8058. doi:10.1097/MD.0000000000008058
   PubMed Web of Science ®Google Scholar
• Onat A, Can G, Kaya H, Hergenc G. ”Atherogenic index of plasma” (log10 triglyceride/high-density lipoprotein-cholesterol) predicts high blood pressure, diabetes, and vascular events. J Clin Lipidol. 2010;4(2):89–98. doi:10.1016/j.jacl.2010.02.005
   PubMed Web of Science ®Google Scholar
• Johansen O, Abdelnoor M, Brekke M, Seljeflot I, Hostmark AT, Arnesen H. Predictors of restenosis after coronary angioplasty. A study on demographic and metabolic variables. Scand Cardiovasc J. 2001;35(2):86–91. doi:10.1080/140174301750164691
   PubMed Web of Science ®Google Scholar
• Moradi H, Streja E, Kashyap ML, Vaziri ND, Fonarow GC, Kalantar-Zadeh K. Elevated high-density lipoprotein cholesterol and cardiovascular mortality in maintenance hemodialysis patients. Nephrol Dial Transplant. 2014;29(8):1554–1562. doi:10.1093/ndt/gfu022
   PubMed Web of Science ®Google Scholar
• Vaziri ND, Moradi H, Pahl MV, Fogelman AM, Navab M. In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide. Kidney Int. 2009;76(4):437–444. doi:10.1038/ki.2009.177
   PubMed Web of Science ®Google Scholar
• Peng J, Luo F, Ruan G, Peng R, Li X. Hypertriglyceridemia and atherosclerosis. Lipids Health Dis. 2017;16(1):233. doi:10.1186/s12944-017-0625-0
   PubMed Web of Science ®Google Scholar
• Verbeek R, Hovingh GK, Boekholdt SM. Non-high-density lipoprotein cholesterol: current status as cardiovascular marker. Curr Opin Lipidol. 2015;26(6):502–510. doi:10.1097/MOL.0000000000000237
   PubMed Web of Science ®Google Scholar
• Shoji T, Masakane I, Watanabe Y, Iseki K, Tsubakihara Y; Committee of Renal Data Registry JSfDT. Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients. Clin J Am Soc Nephrol. 2011;6(5):1112–1120. doi:10.2215/CJN.09961110
   PubMed Web of Science ®Google Scholar
• Chiu H, Wu PY, Huang JC, et al. There is a U shaped association between non high density lipoprotein cholesterol with overall and cardiovascular mortality in chronic kidney disease stage 3–5. Sci Rep. 2020;10(1):12749. doi:10.1038/s41598-020-69794-2
   PubMed Web of Science ®Google Scholar
• Shapiro MD, Fazio S. Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease. F1000Res. 2017;6:134. doi:10.12688/f1000research.9845.1
   PubMedGoogle Scholar
• El Harchaoui K, van der Steeg WA, Stroes ES, et al. Value of low-density lipoprotein particle number and size as predictors of coronary artery disease in apparently healthy men and women: the EPIC-Norfolk Prospective Population Study. J Am Coll Cardiol. 2007;49(5):547–553. doi:10.1016/j.jacc.2006.09.043
   PubMed Web of Science ®Google Scholar
• Desmeules S, Arcand-Bosse JF, Bergeron J, Douville P, Agharazii M. Nonfasting non-high-density lipoprotein cholesterol is adequate for lipid management in hemodialysis patients. Am J Kidney Dis. 2005;45(6):1067–1072. doi:10.1053/j.ajkd.2005.03.002
   PubMed Web of Science ®Google Scholar
• Zhang N, Hu X, Zhang Q, et al. Non-high-density lipoprotein cholesterol: high-density lipoprotein cholesterol ratio is an independent risk factor for diabetes mellitus: results from a population-based cohort study. J Diabetes. 2018;10(9):708–714. doi:10.1111/1753-0407.12650
   PubMed Web of Science ®Google Scholar
• Kim SW, Jee JH, Kim HJ, et al. Non-HDL-cholesterol/HDL-cholesterol is a better predictor of metabolic syndrome and insulin resistance than apolipoprotein B/apolipoprotein A1. Int J Cardiol. 2013;168(3):2678–2683. doi:10.1016/j.ijcard.2013.03.027
   PubMed Web of Science ®Google Scholar
• Kouvari M, Panagiotakos DB, Chrysohoou C, Georgousopoulou EN, Tousoulis D, Pitsavos AC. Sex-related differences of the effect of lipoproteins and apolipoproteins on 10-year cardiovascular disease risk; insights from the ATTICA study (2002–2012). Molecules. 2020;25(7). doi:10.3390/molecules25071506
   PubMed Web of Science ®Google Scholar
• Xia W, Yao X, Chen Y, Lin J, Vielhauer V, Hu H. Elevated TG/HDL-C and non-HDL-C/HDL-C ratios predict mortality in peritoneal dialysis patients. BMC Nephrol. 2020;21(1):324. doi:10.1186/s12882-020-01993-5
   PubMed Web of Science ®Google Scholar
• Virani SS, Catellier DJ, Pompeii LA, et al. Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study. Atherosclerosis. 2011;219(2):596–602. doi:10.1016/j.atherosclerosis.2011.08.001
   PubMed Web of Science ®Google Scholar
• Wu TT, Gao Y, Zheng YY, Ma YT, Xie X. Atherogenic index of plasma (AIP): a novel predictive indicator for the coronary artery disease in postmenopausal women. Lipids Health Dis. 2018;17(1):197. doi:10.1186/s12944-018-0828-z
   PubMedGoogle Scholar